According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$106.97. In 2022 the company made an earnings per share (EPS) of -HK$102.17 a decrease over its 2021 EPS that were of -HK$62.80.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$108.16 | 5.86% |
2022 | -HK$102.17 | 62.69% |
2021 | -HK$62.80 | 28.57% |
2020 | -HK$48.85 | -53.33% |
2019 | -HK$104.67 | -53.61% |
2018 | -HK$225.62 | 10.23% |
2017 | -HK$204.69 | 22.22% |
2016 | -HK$167.47 | -94.55% |
2015 | -HK$3,070 | 728.93% |
2014 | -HK$370.41 | 92.1% |
2013 | -HK$192.83 | -66.24% |
2012 | -HK$571.20 | -77.97% |
2011 | -HK$2,593 | 217.82% |
2010 | -HK$815.86 | 954.43% |
2009 | -HK$77.38 | -2273.56% |
2008 | HK$3.56 | -209.82% |
2007 | -HK$3.24 | -42.44% |
2006 | -HK$5.63 | -82.2% |
2005 | -HK$31.64 | 2797.22% |
2004 | -HK$1.09 | -41.9% |
2003 | -HK$1.88 | -99.17% |
2002 | -HK$227.53 | 8.12% |
2001 | -HK$210.45 |